351 related articles for article (PubMed ID: 32599245)
21. Integrative transcriptomics analysis of lung epithelial cells and identification of repurposable drug candidates for COVID-19.
Islam T; Rahman MR; Aydin B; Beklen H; Arga KY; Shahjaman M
Eur J Pharmacol; 2020 Nov; 887():173594. PubMed ID: 32971089
[TBL] [Abstract][Full Text] [Related]
22. Targeting SARS-CoV-2 receptors as a means for reducing infectivity and improving antiviral and immune response: an algorithm-based method for overcoming resistance to antiviral agents.
Gelman R; Bayatra A; Kessler A; Schwartz A; Ilan Y
Emerg Microbes Infect; 2020 Dec; 9(1):1397-1406. PubMed ID: 32490731
[TBL] [Abstract][Full Text] [Related]
23. Potential Drugs Targeting Early Innate Immune Evasion of SARS-Coronavirus 2 via 2'-O-Methylation of Viral RNA.
Encinar JA; Menendez JA
Viruses; 2020 May; 12(5):. PubMed ID: 32397643
[TBL] [Abstract][Full Text] [Related]
24. Role of SARS-CoV-2 in Altering the RNA-Binding Protein and miRNA-Directed Post-Transcriptional Regulatory Networks in Humans.
Srivastava R; Daulatabad SV; Srivastava M; Janga SC
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993015
[TBL] [Abstract][Full Text] [Related]
25. Interferon-Induced Transmembrane Protein (IFITM3) Is Upregulated Explicitly in SARS-CoV-2 Infected Lung Epithelial Cells.
Hachim MY; Al Heialy S; Hachim IY; Halwani R; Senok AC; Maghazachi AA; Hamid Q
Front Immunol; 2020; 11():1372. PubMed ID: 32595654
[TBL] [Abstract][Full Text] [Related]
26. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
Front Immunol; 2021; 12():789317. PubMed ID: 34975885
[TBL] [Abstract][Full Text] [Related]
27. Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19.
Barh D; Tiwari S; Weener ME; Azevedo V; Góes-Neto A; Gromiha MM; Ghosh P
Comput Biol Med; 2020 Nov; 126():104051. PubMed ID: 33131530
[TBL] [Abstract][Full Text] [Related]
28. Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients.
Zhou Z; Ren L; Zhang L; Zhong J; Xiao Y; Jia Z; Guo L; Yang J; Wang C; Jiang S; Yang D; Zhang G; Li H; Chen F; Xu Y; Chen M; Gao Z; Yang J; Dong J; Liu B; Zhang X; Wang W; He K; Jin Q; Li M; Wang J
Cell Host Microbe; 2020 Jun; 27(6):883-890.e2. PubMed ID: 32407669
[TBL] [Abstract][Full Text] [Related]
29. Network perturbation analysis in human bronchial epithelial cells following SARS-CoV2 infection.
Nunnari G; Sanfilippo C; Castrogiovanni P; Imbesi R; Li Volti G; Barbagallo I; Musumeci G; Di Rosa M
Exp Cell Res; 2020 Oct; 395(2):112204. PubMed ID: 32735892
[TBL] [Abstract][Full Text] [Related]
30. Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells.
Appelberg S; Gupta S; Svensson Akusjärvi S; Ambikan AT; Mikaeloff F; Saccon E; Végvári Á; Benfeitas R; Sperk M; Ståhlberg M; Krishnan S; Singh K; Penninger JM; Mirazimi A; Neogi U
Emerg Microbes Infect; 2020 Dec; 9(1):1748-1760. PubMed ID: 32691695
[TBL] [Abstract][Full Text] [Related]
31. Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans.
Arunachalam PS; Wimmers F; Mok CKP; Perera RAPM; Scott M; Hagan T; Sigal N; Feng Y; Bristow L; Tak-Yin Tsang O; Wagh D; Coller J; Pellegrini KL; Kazmin D; Alaaeddine G; Leung WS; Chan JMC; Chik TSH; Choi CYC; Huerta C; Paine McCullough M; Lv H; Anderson E; Edupuganti S; Upadhyay AA; Bosinger SE; Maecker HT; Khatri P; Rouphael N; Peiris M; Pulendran B
Science; 2020 Sep; 369(6508):1210-1220. PubMed ID: 32788292
[TBL] [Abstract][Full Text] [Related]
32. Oxytocin's anti-inflammatory and proimmune functions in COVID-19: a transcriptomic signature-based approach.
Imami AS; O'Donovan SM; Creeden JF; Wu X; Eby H; McCullumsmith CB; Uvnäs-Moberg K; McCullumsmith RE; Andari E
Physiol Genomics; 2020 Sep; 52(9):401-407. PubMed ID: 32809918
[TBL] [Abstract][Full Text] [Related]
33. Deciphering the Role of Host Genetics in Susceptibility to Severe COVID-19.
Carter-Timofte ME; Jørgensen SE; Freytag MR; Thomsen MM; Brinck Andersen NS; Al-Mousawi A; Hait AS; Mogensen TH
Front Immunol; 2020; 11():1606. PubMed ID: 32695122
[TBL] [Abstract][Full Text] [Related]
34. Investigating the mechanism of ShuFeng JieDu capsule for the treatment of novel Coronavirus pneumonia (COVID-19) based on network pharmacology.
Chen X; Yin YH; Zhang MY; Liu JY; Li R; Qu YQ
Int J Med Sci; 2020; 17(16):2511-2530. PubMed ID: 33029094
[TBL] [Abstract][Full Text] [Related]
35. Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse.
Gardinassi LG; Souza COS; Sales-Campos H; Fonseca SG
Front Immunol; 2020; 11():1636. PubMed ID: 32670298
[TBL] [Abstract][Full Text] [Related]
36. A data-driven hypothesis on the epigenetic dysregulation of host metabolism by SARS coronaviral infection: Potential implications for the SARS-CoV-2 modus operandi.
Vavougios GD
Med Hypotheses; 2020 Jul; 140():109759. PubMed ID: 32344305
[TBL] [Abstract][Full Text] [Related]
37. A Dynamic Immune Response Shapes COVID-19 Progression.
Ong EZ; Chan YFZ; Leong WY; Lee NMY; Kalimuddin S; Haja Mohideen SM; Chan KS; Tan AT; Bertoletti A; Ooi EE; Low JGH
Cell Host Microbe; 2020 Jun; 27(6):879-882.e2. PubMed ID: 32359396
[TBL] [Abstract][Full Text] [Related]
38. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.
Blanco-Melo D; Nilsson-Payant BE; Liu WC; Uhl S; Hoagland D; Møller R; Jordan TX; Oishi K; Panis M; Sachs D; Wang TT; Schwartz RE; Lim JK; Albrecht RA; tenOever BR
Cell; 2020 May; 181(5):1036-1045.e9. PubMed ID: 32416070
[TBL] [Abstract][Full Text] [Related]
39. A connectivity map-based drug repurposing study and integrative analysis of transcriptomic profiling of SARS-CoV-2 infection.
Mousavi SZ; Rahmanian M; Sami A
Infect Genet Evol; 2020 Dec; 86():104610. PubMed ID: 33130005
[TBL] [Abstract][Full Text] [Related]
40. Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients.
Xiong Y; Liu Y; Cao L; Wang D; Guo M; Jiang A; Guo D; Hu W; Yang J; Tang Z; Wu H; Lin Y; Zhang M; Zhang Q; Shi M; Liu Y; Zhou Y; Lan K; Chen Y
Emerg Microbes Infect; 2020 Dec; 9(1):761-770. PubMed ID: 32228226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
